EXTON, PA — Frontage Labs has successfully launched an outstanding new initiative in support of both the local community and the global response to the COVID-19 pandemic.
Frontage Labs’ highly experienced central lab team has successfully developed COVID-19 RT-PCR and IgM testing capability at their headquarters located at 700 Pennsylvania Drive in Exton, PA. These platforms have proven to be highly reliable and are nationally recognized as essential tools in managing the spread of the novel coronavirus. Frontage Labs believes it is their duty to contribute to the country’s fight against the virus and are proud of their team of physicians and medical technologists who have answered the call.
As part of their testing capabilities, Frontage Labs is conducting RT-PCR (nucleic acid) testing on nasopharyngeal swab specimens and IgM antibody testing on fingerstick blood specimens. Frontage Labs is one of the few labs in the region which can provide fast turnaround time results for these tests. They anticipate that their services will be of value to local governments, large corporations, school districts, airlines, etc., as well as individuals for their COVID-19 testing needs. Frontage Labs’ personnel operate under extensive safety protocols, which have been rigorously developed and implemented.
“We are proud of our highly experienced team who has successfully developed this innovative testing capability and truly believe our efforts of fighting against the COVID-19 will benefit our community.” Dr. John Lin, EVP & Global Head, Bioanalytical and Biologics Services at Frontage stated.
To learn more about Frontage Labs’ testing services or to participate in the testing, visit https://www.frontagelab.com/covid-19-information/.
Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.